Connect with us

Health

AbbVie Inc (NYSE:ABBV) Showcases Leadership In HCV With New MAVYRET™ Report To Be Introduced At The Liver Meeting® 2017

Published

on

AbbVie Inc (NYSE:ABBV) reported that it will showcase new data assessing MAVYRET™, its once-daily, ribavirin-free therapy for people with chronic hepatitis C virus infection across all key genotypes (GT1-6), at the yearly meeting of the AASLD.

Sixteen company scientific abstracts have been approved, including two oral presentations evaluating the application of MAVYRET in patients across genotypes with compensated cirrhosis and treatment-naïve subjects with genotype 3 HCV. These patients have historically had limited treatment alternatives. A third oral presentation assesses adherence to cure with MAVYRET in the clinical development plan. The Liver Meeting® 2017 is scheduled to take place from October 20 to October 24, 2017.

The details

Janet Hammond, M.D., Ph.D., the VP of Infectious Diseases Development at AbbVie, expressed that the company’s data presentations at The Liver Meeting 2017 reinforce their commitment to patients with hepatitis C. These data add to a strong collection of clinical study data to further improve scientific knowledge of MAVYRET’s efficacy and safety across a number of patient populations.

The next big cannabis story to hit North America is Phoenix Life Science International (PLSI), traded in the US, but with the largest global production based in the tropics and a license to distribute worldwide. Take a look at Phoenix Life Science International PLSI), Its currently trading under $18 dollars per share on the OTC markets. Learn More Now!

Researchers will also showcase data received from the MAVYRET clinical program assessing patients with metabolic, renal and cardiovascular conditions and data on HCV patient preferences.

Fred Poordad, M.D. expressed that on the back of AASLD’s newly introduced HCV treatment guidance, they are thrilled to witness additional data on MAVYRET across a broad range of subjects. The updated recommendations on accessible treatments, including the application of MAVYRET in the majority of people, serve as an additional source of data to assist physicians make treatment decisions.

In the last trading session, the stock price of AbbVie declined 0.35% to close the day at $91.42. The decline came at a share volume of 4.82 million compared to average share volume of 7.93 million. After the recent decline, the market cap of firm was seen at around $146 billion.

Pushing the barriers for global distribution, Phoenix Life Science International (PLSI) is the next cannabis play. Just think Canopy x 100, that is how big their plantation in the tropics will be. No lights, no green houses, just maximum growth + minimal cost = home run. Learn More Now!

   

Learn More About PLSI at your brokerage today!

         

TRENDING STORIES

Business3 weeks ago

The Sales Growth Trend Persists for PotNetwork Holdings Inc (OTCMKTS:POTN)

PotNetwork Holdings Inc (OTCMKTS:POTN) is perhaps THE juggernaut CBD story, aside from CVSI, over the past 12 months. That is...

Business1 month ago

Hemp Inc (OTCMKTS:HEMP) Looks to Garner Support on Expansion and CBD Talk

Hemp Inc (OTCMKTS:HEMP) shares recently slipped under technical support in the $0.025. The stock has possibly found some bids in...

INDUSTRIAL HEMP1 month ago

How to View the Current Action in Hemp Inc (OTCMKTS:HEMP)

One stock that has started to key on potential support in a lateral range is Hemp Inc (OTCMKTS:HEMP). The stock...

INDUSTRIAL HEMP6 months ago

Near-Term Headwinds Hit Scotts Miracle-Gro Co (NYSE:SMG) With A Huge Impact

Bank of America Corp (NYSE:BAC) has disclosed that Scotts Miracle-Gro Co (NYSE:SMG) has lately been experiencing several near term risks....

INDUSTRIAL HEMP6 months ago

Argitek Holdings Inc (OTCMKTS:AGTK) To Focus On Acquisition, Revenues & Profitability In 2018

Argitek Holdings Inc (OTCMKTS:AGTK) recently revealed that in 2018, the company’s main focus will be the acquisition, revenues, and profitability....

INDUSTRIAL HEMP6 months ago

PharmaCyte Biotech Inc (OTCMKTS:PMCB) Completes Pore Size Studies & 29 Tests Useful In Pancreatic Cancer Therapy

PharmaCyte Biotech Inc (OTCMKTS:PMCB) has said that the cells it is planning to use in the clinical trial in patients...

INDUSTRIAL HEMP6 months ago

Puration Inc (OTCMKTS:PURA) To Apply For Canadian Recreational Cannabis Cultivation License; To Give EVERx CBD Sports Water Free Samples

Puration Inc (OTCMKTS:PURA) recently announced that it will be applying for the Canadian recreational cannabis cultivation license. The confirmation came...

INDUSTRIAL HEMP6 months ago

Marijuana Company Of America Inc (OTCMKTS:MCOA)’s JV Completes 10,000 Sq. Ft. Greenhouse Set up; Provides Update on Oregon Project

Marijuana Company Of America Inc (OTCMKTS:MCOA) recently announced that its Joint Venture with Bougainville Ventures Inc. based in Washington has...

INDUSTRIAL HEMP6 months ago

Lifestyle Delivery Systems Inc.(OTCMKTS:LDSYF)’s CSPA Group Inc. Receives 15000 Reveur Units & 300 Liters Distillates’ Purchase Orders In Two Different Deals

Lifestyle Delivery Systems Inc. (OTCMKTS:LDSYF) recently made two big announcements related to the receipt of two open purchase orders to...

INDUSTRIAL HEMP6 months ago

Viaderma Inc (OTCMKTS:VDRM) Provides Update On Its Flagship Product Vitastem; Signs $250,000 Agreement With Vage Nigeria Ltd.

Viaderma Inc (OTCMKTS:VDRM), a publicly traded specialty pharmaceutical company recently announced an update on the sales of its flagship product...

Advertisement
Advertisement

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Play